Paper Review Records
All Paper Review Records
25 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
164
days
Defining a Therapeutic Window for Venetoclax in Post‐Transplant Maintenance Therapy for High‐Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes
Authors
Cuicui Lyu; Tianle Xie; Yedi Pu; Xianshuang Luan; Xia Xiao; Mingfeng Zhao; Hairong LyuShow moreShow less
Affiliations
1. Department of Hematology Tianjin First Central Hospital Tianjin Thrombosis and Hemostasis Institute Tianjin China; 2. Department of Oncology Xinzhou People's Hospital Xinzhou Shanxi ChinaShow moreShow less
314
days
DNA Replication Stress‐Induced Transcriptome of Human Burkitt's Lymphoma Identifies Reciprocal Regulation Between MBD1 and BCL6 During Germinal Center‐Derived B‐Lymphomagenesis
Authors
Santosh Kumar Gothwal; Kyoko Oichai; Hongtae Kim; Kyungjae Myung; Jacqueline H. BarlowShow moreShow less
Affiliations
1. Institute of Frontier Science Initiative Kanazawa University Kanazawa Japan; 2. Center for Genomic Integrity Institute for Basic Science Daejeon South Korea; 3. Department of Biochemistry Graduate School of Medicine Tohoku University Sendai Japan; 4. Department of Biological Sciences Ulsan National Institute of Science and Technology Ulsan Korea; 5. Department of Microbiology and Molecular Genetics University of California Davis Davis California USAShow moreShow less
224
days
Decoding the Heterogeneity of Diffuse Large B‐Cell Lymphomas: A Comprehensive Genetic, Transcriptomic, and Phenotypic Profiling of B‐Cell Lymphoma Cell Lines
Authors
Marina Pérez‐Aguilera; Lucía Pedrosa; Sagrario Gómez; Sara Salazar‐Ortego; Ismael Fernández‐Miranda; Rafael Muñoz‐Viana; Paloma Martín‐Acosta; Beatriz L. Martín‐Lunas; Rebeca Jimeno; Natalia Yanguas‐Casás; Beatriz Horcajo; Giovana Roncador; José A. Martínez‐Climent; Ana Ortega‐Molina; Margarita Sánchez‐BeatoShow moreShow less
Affiliations
1. Medical Oncology Department Lymphoma Research Group Hospital Universitario Puerta de Hierro‐Majadahonda IDIPHISA Madrid Spain; 2. Immune System Development and Function Department Metabolism in Cancer and Aging Research Group Centro de Biologia Molecular Severo Ochoa (CBM), CSIC—Universidad Autonoma de Madrid Madrid Spain; 3. Bioinformatics Unit Hospital Universitario Puerta de Hierro‐Majadahonda IDIPHISA Madrid Spain; 4. Pathology Department Cancer Molecular Pathology Group Hospital Puerta de Hierro‐Majadahonda IDIPHISA Madrid Spain; 5. Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES) Madrid Spain; 6. Monoclonal Antibodies Core Unit, Biotechnology Program, Spanish National Cancer Research Centre (CNIO) Madrid Spain; 7. Department of Haematology Center for Applied Medical Research Cancer Center Clinica Universidad de Navarra IDISNA CIBERONC Pamplona SpainShow moreShow less
32
days
FLT3‐ITD Measurable Residual Disease in Acute Myeloid Leukemia: Recommended, but Not Yet Self‐Sufficient
Authors
Francesco AlbanoShow moreShow less
Affiliations
1. Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe‐J)‐Hematology and Stem Cell Transplantation Unit University of Bari “Aldo Moro” Bari ItalyShow moreShow less
67
days
Early Serum Free Light Chain Response in Newly Diagnosed Multiple Myeloma: Documented Earlier Than MRD and Complementary in Prognosis
Authors
Yubiao Pan; Yue Wang; Yaqin Xiong; Panpan Li; Chenqi Yu; Peng LiuShow moreShow less
Affiliations
1. Department of Hematology Zhongshan Hospital Fudan University Shanghai ChinaShow moreShow less
268
days
A Phase 1 Trial of Duvelisib and Oral Azacitidine in Relapsed/Refractory T‐Cell Lymphoma
Authors
Hayder Saeed; Melanie Mediavilla Varela; Eva Sahakian; Mahrukh Naqvi; Qianxing Mo; Ling Zhang; Rikesh Makanji; Yumeng Zhang; Ning Dong; Leidy Isenalumhe; Sameh Gaballa; Julio Chavez; Bijal Shah; Celeste Bello; Lubomir Sokol; Javier Pinilla‐IbarzShow moreShow less
Affiliations
1. Department of Malignant Hematology Moffitt Cancer Center Tampa Florida USA; 2. Department of Biostats and Bioinformatics Moffitt Cancer Center Tampa Florida USA; 3. Department of Pathology Moffitt Cancer Center Tampa Florida USA; 4. Department of Radiology Moffitt Cancer Center Tampa Florida USAShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days